News & Views

Funding moves Platform Technology Forward

Completion of a $13.5M financing round, will see Munich-based GNA Biosolutions GmbH advance development and secure IVD-CE marking of its first Point of Care molecular diagnostic platform which uses Pulse Controlled Amplification (PCA), which amplifies nucleic acids captured directly from complex...

Dec 05 2019 Read 96 Times


Digital Edition

Lab Asia December 2019

December 2019

In This Edition Mass Spectrometry & Spectroscopy - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - Non-equivalent, Multivalen...

View all digital editions

Events

Nepal Lab

Dec 13 2019 Kathmandu, Nepal

SLAS 2020

Jan 25 2020 San Diego, CA, USA

Arab Health

Jan 27 2020 Dubai, UAE

Nano Tech 2020

Jan 29 2020 Tokyo, Japan

HTC-16

Jan 29 2020 Ghent, Belgium

View all events